期刊
CANCER LETTERS
卷 336, 期 2, 页码 325-337出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2013.03.023
关键词
Resveratrol; Esophageal squamous cell carcinoma; Autophagy; Apoptosis
类别
资金
- National Natural Science Foundation of China [81071736, 30973508, 81172089]
- Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20104402110005]
The anti-cancer activity of resveratrol in human esophageal squamous cell carcinoma (ESCC) was investigated focusing on the role of autophagy and its effects on apoptotic cell death. We demonstrated that resveratrol inhibits ESCC cell growth in a dose-dependent manner by inducing cell cycle arrest at the sub-G1 phase and resulting in subsequent apoptosis. Mechanistically, resveratrol-induced autophagy in the ESCC cells is AMPK/mTOR pathway independent. Since both pharmacological and genetic inhibition of autophagy enhanced the resveratrol-induced cytotoxicity to the ESCC cells, this provided a novel strategy in potentiating the anti-cancer effects of resveratrol and other chemotherapeutic reagents in ESCC cancer treatment. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据